Swiss Biotech Starts Phase II Trial to Treat Motor Symptoms of Parkinson’s

Roche and Ireland’s Biggest Biopharma Take Their Parkinson’s Antibody to Phase II

UPDATE: Italian Pharma receives €11M for Parkinson’s Drug Approval

Interview 20 Apr 2017

Newron’s Journey to Launch the First Parkinson’s Drug in 11 Years


New Grant to Advance a Whole New Treatment Against Parkinson’s in the UK

Swiss Parkinson’s Biotech raises Massive €29M in Series B from Top European VCs

This New Biotech wants to Regrow Neurons to cure Parkinson’s

ITW: Prexton Therapeutics CEO explains Development of new Parkinson’s Drug

Vienna-based Biotech raises €10M to fight Metabolic diseases and Parkinson’s

Biotech of the Week: Pharnext, developing next level drugs against Alzheimer’s and Parkinson’s disease

It’s World Parkinson’s Disease Day! #EndParkinsons

Swissmedic Approves Zambon and Newron Therapy against Parkinson’s